期刊文献+

RhoA/Rho激酶信号通路与肺动脉高压 被引量:14

RhoA/Rho-kinase signaling pathway and pulmonary arterial hypertension
暂未订购
导出
摘要 目前研究已发现RhoA/Rho激酶信号通路参与了人体多种疾病的形成,如高血压、冠心病、脑率中等。肺动脉高压的病理学改变包括内皮细胞的损伤、增殖,肺血管平滑肌细胞的高反应性,炎症细胞迁移和黏附以及肺小血管形成和栓塞;Rho激酶调节细胞的多种生物学行为和功能,如收缩、黏附、迁移、增殖、凋亡、基因表达等。研究表明RhoA/Rho激酶信号通路通过多种方式参与了肺动脉高压的形成。 It has been shown that RhoA/Rho kinase signaling pathway is involved in the pathogenesis of multiple human diseases such as hypertension,coronary heart disease,stroke and so on.Pathological changes of pulmonary arterial hypertension include endothelial cell damage,proliferation,hyper-responsiveness of pulmonary vascular smooth muscle cells,inflammatory cell migration and adhesion,angiogenesis,and pulmonary embolism.Rho kinase regulates lots of biological cellular functions such as contraction,adhesion,migration,proliferation,apoptosis,gene expression and so on.Thre is ample evidence suggests that RhoA/Rho kinase signaling pathway is involved in the development of pulmonary hypertension.
出处 《国际病理科学与临床杂志》 CAS 2011年第3期256-258,共3页 Journal of International Pathology and Clinical Medicine
关键词 RHOA/RHO激酶 肺动脉高压 肺高压 Rho-kinase pulmonary arterial hypertension pulmonary hypertension
  • 相关文献

参考文献7

  • 1代丽,吴尚洁.阿托伐他汀抑制RhoA/Rho激酶活性逆转低氧性肺动脉高压大鼠肺动脉高压和肺血管重构[J].中南大学学报(医学版),2011,36(1):58-63. 被引量:27
  • 2Brown JH,Del RE DP, Sussman MA. The Rac and Rho hall of fame:a decade of hypertrophic signaling hits[J]. Circ Res,2006, 98(6) :730-742.
  • 3Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension[J]. N Engl Med,2004, 351 (14) : 1425-1436.
  • 4Abe K, SKimokawa H, Morikawa K, et al, Long-term treament with a Rho-kinase inhibitor improves monocrotatine-induced fatal pulmonary hypertension[J ]. Circ Res, 2004,94 (3) :385-393.
  • 5Xu ZE,Kantores C, lvanovska J, et al. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and re- verses remodeling in juvenile rats with chronic pulmonary hypertension[J]. Heart Circ Physiol,2010, 299(6) :H1854-864.
  • 6Loirand G, Guem P, Pacaud P. Rho kinases in cardiovascular physiology and pathophysiology [J ]. Circ Res, 2006, 98 ( 3 ) : 322- 334.
  • 7邢西迁,甘烨,吴尚洁.Rho/Rho激酶信号通路与肺部疾病[J].国际病理科学与临床杂志,2007,27(1):85-88. 被引量:5

二级参考文献39

  • 1吴尚洁,邢西迁,甘烨,赵水平,陈平.阿托伐他汀对脂多糖诱导下人肺上皮细胞C反应蛋白表达的影响[J].中南大学学报(医学版),2009,34(2):104-108. 被引量:3
  • 2薛全福,谢剑鸣.常压缺氧性大鼠肺动脉高压模型的建立[J].中华结核和呼吸杂志,1989,12(6):350-352. 被引量:157
  • 3邢西迁,甘烨,吴尚洁.Rho激酶与哮喘气道高反应性[J].国际病理科学与临床杂志,2006,26(6):499-502. 被引量:3
  • 4Cool C D,Groshong S D,Oakey J,et al.Pulmonary hypertension:cellular and molecular mechanisms[J].Chest,2005,128(6 Suppl):565S-571S.
  • 5Badejo A M Jr,Dhaliwal J S,Casey D B,et al.Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat[J].Am J Physiol Lung Cell Mol Physiol,2008,295(5):L828-L836.
  • 6Rikitake Y,Liao J K.Rho GTPases,statins,and nitric oxide[J].Circ Res,2005,97(12):1232-1235.
  • 7Oka M,Homma N,Taraseviciene-Stewart L,et al.Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats[J].Circ Res,2007,100 (6):923-929.
  • 8Guerard P,Rakotoniaina Z,Goirand F,et al.The HMG-CoA reductase inhibitor,pravastatin,prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS[J].Naunyn Schmiedebergs Arch Pharmacol,2006,373(6):401-414.
  • 9Stenmark K R,McMurtry I F.Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension:A time for reappraisal?[J].Circ Res,2005,97(2):95-98.
  • 10Morty R E,Nejman B,Kwapiszewska G,et al.Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial.Hypertension arterioscler[J].Arterioscler Thromb Vasc Biol,2007,27(5):1072-1078.

共引文献30

同被引文献148

引证文献14

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部